These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3481329)

  • 1. A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.
    White LO; MacGowan AP; Lovering AM; Reeves DS; Mackay IG
    Drugs; 1987; 34 Suppl 1():56-61. PubMed ID: 3481329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure.
    White LO; MacGowan AP; Mackay IG; Reeves DS
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():65-72. PubMed ID: 3182464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ofloxacin in patients on haemodialysis treatment.
    Dörfler A; Schulz W; Burkhardt F; Zichner M
    Drugs; 1987; 34 Suppl 1():62-70. PubMed ID: 3481330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary tract excretion of ofloxacin in man.
    Kazmierczak A; Pechinot A; Duez JM; Haas O; Favre JP
    Drugs; 1987; 34 Suppl 1():39-43. PubMed ID: 3481327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of ofloxacin from blood to sputum.
    Davies BI; Maesen FP; Geraedts WH; Baur C
    Drugs; 1987; 34 Suppl 1():26-32. PubMed ID: 3481324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function.
    Höffler D; Koeppe P
    Drugs; 1987; 34 Suppl 1():51-5. PubMed ID: 3125032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion of ofloxacin into human lung tissue.
    Couraud L; Fourtillan JB; Saux MC; Bryskier A; Vincent du Laurier M
    Drugs; 1987; 34 Suppl 1():37-8. PubMed ID: 3481326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
    Nawishy S; Moukhtar I; Sabbour M
    Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of muscle microdialysis to evaluate the concentrations of the fluoroquinolones pazufloxacin and ofloxacin in the tissue interstitial fluids of rats.
    Araki H; Ogake N; Minami S; Watanabe Y; Narita H; Tamai I; Tsuji A
    J Pharm Pharmacol; 1997 Nov; 49(11):1141-4. PubMed ID: 9401953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
    Daniel JP; Moulin B; Christmann D
    Ann Pharm Fr; 2004 May; 62(3):177-85. PubMed ID: 15243351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of T-3761 in healthy volunteers.
    Saito A
    Drugs; 1995; 49 Suppl 2():335-6. PubMed ID: 8549353
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantification of the enantiomers of ofloxacin in biological fluids by high-performance liquid chromatography.
    Lehr KH; Damm P
    J Chromatogr; 1988 Mar; 425(1):153-61. PubMed ID: 3162915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of ofloxacin tablets in comparison to oral solution.
    Malerczyk V; Verho M; Korn A; Rangoonwala R
    Curr Med Res Opin; 1987; 10(8):514-20. PubMed ID: 3479296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis.
    McMullin CM; Brown NM; Brown IM; Tomson CR; White LO; Reeves DS; MacGown AP
    J Antimicrob Chemother; 1997 Jun; 39(6):829-31. PubMed ID: 9222057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Chan MK; Chau PY; Chan WW
    Clin Nephrol; 1987 Dec; 28(6):277-80. PubMed ID: 3481692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of new quinolones.
    Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reimnitz D; Borner K; Koeppe P
    Drugs; 1987; 34 Suppl 1():21-5. PubMed ID: 3481323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of food on the pharmacokinetics of ofloxacin.
    Verho M; Malerczyk V; Dagrosa E; Korn A
    Curr Med Res Opin; 1986; 10(3):166-71. PubMed ID: 3460737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ofloxacin. An overview.
    Flor S
    Am J Med; 1989 Dec; 87(6C):24S-30S. PubMed ID: 2603892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.